QualityStocksNewsBreaks Archives

TuesdayAug 11, 2026 9:30 am

QualityStocksNewsBreaks – Roth Capital Partners Affiliate Roth Canada Expands Toronto Operations, Names David Parsons Head of Canadian Institutional Sales

Roth Capital Partners announced that its Canadian affiliate, Roth Canada, is expanding its Toronto operations with the appointment of David Parsons as Head of Canadian Institutional Sales and the establishment of new offices at 8 King St. E. Parsons, who brings more than 25 years of capital markets experience, will provide Canadian investors access to ROTH management teams, research and proprietary offerings while driving Canadian distribution on investment banking mandates. Michael Tait will lead the firm’s Mining and Diversified Investment Banking teams from the Toronto offices. The expansion follows the opening of Roth Canada’s Calgary office, where Tony Loria leads…

TuesdayAug 11, 2026 9:10 am

QualityStocksNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial on AI Power and Infrastructure Demand

AZIO AI Holdings (NASDAQ: AZIO) announced its placement in an AINewsWire (“AINW”) editorial examining how surging artificial intelligence adoption is driving increased demand for power, data-center capacity, high-speed connectivity and next-generation GPU systems. The editorial, “As AI Races Ahead, the Real Battle Is Over Power and Infrastructure,” highlights AZIO’s strategy of building an integrated infrastructure platform spanning digital power, data-center development, enterprise fiber and GPU deployment, including its Master Services Agreement with AT&T, power and hosting agreement and recently announced letter of intent (“LOI”) with Power Champion. To view the full press release, visit https://ibn.fm/74hce About AZIO AI Holdings, Inc. AZIO AI Holdings, Inc.…

MondayAug 10, 2026 3:30 pm

QualityStocksNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Pursues Strategic Growth in Emerging Critical Minerals Region

Greenland Mines (NASDAQ: GRML) is pursuing a diversified critical minerals strategy focused on Greenland as demand for resources essential to electric vehicles, renewable energy, semiconductors, advanced computing and defense technologies continues to grow. The company aims to build a portfolio of projects spanning multiple strategically important commodities rather than relying on a single mineral, while also pursuing acquisitions and partnerships to expand its position. A recent article highlights Greenland’s substantial geological potential and growing international attention as governments seek more secure and diversified mineral supply chains. Greenland Mines plans to advance prospective assets through exploration and geological evaluation while emphasizing responsible…

MondayAug 10, 2026 2:43 pm

QualityStocksNewsBreaks – Forward Industries Inc. (NASDAQ: FWDI) Expands Solana Holdings and Institutional Capital Access

Forward Industries (NASDAQ: FWDI) expanded its Solana treasury by more than 500,000 SOL during fiscal Q3 2026 at an average purchase price of approximately $79 per SOL, bringing its holdings to 7.55 million SOL as of June 30. The company also sold 93,642 shares through its at-the-market offering while reporting 36% annualized SOL-per-share growth, which it says demonstrates its ability to raise capital in an accretive manner. Following inclusion in the Russell 2000 and Russell 3000 indexes, Forward says it has additional access to institutional capital, while its proprietary fwdSOL staking token provides another source of liquidity. To view the full…

MondayAug 10, 2026 10:50 am

QualityStocksNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial on AI Power, Infrastructure Demand

AZIO AI Holdings (NASDAQ: AZIO) is featured in an AINewsWire editorial titled “As AI Races Ahead, the Real Battle Is Over Power and Infrastructure,” examining how accelerating artificial intelligence adoption is driving demand for the physical infrastructure required to support AI computing. The editorial highlights AZIO AI integrated infrastructure strategy, including its planned 500-megawatt Texas AI data-center campus, Master Services Agreement with AT&T for enterprise fiber connectivity and power purchase and AI infrastructure hosting agreement with Power Champion Investment Limited. The editorial also highlights AZIO AI recently announced letter of intent with Power Champion for the proposed acquisition of 128…

MondayAug 10, 2026 9:30 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Secures $10 Million Strategic Private Placement With Eric Sprott

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced a strategic non-brokered private placement with Eric Sprott for gross proceeds of $10 million. The financing consists of 4 million units priced at $2.50 each, to be subscribed for by 2176423 Ontario Ltd., a corporation beneficially owned by Sprott. Each unit includes one common share and one warrant exercisable at $3.25 for 24 months. Closing is anticipated on or about Aug. 17, 2026, subject to customary conditions, including Canadian Securities Exchange approval. MAX Power…

MondayAug 10, 2026 9:10 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (“IND”) application for Lucid-MS (Lucid-21-302), clearing the company to advance the patented, first-in-class multiple sclerosis candidate into Phase 2 clinical development. The planned randomized, double-blind, placebo-controlled study will evaluate efficacy, safety and tolerability in people with MS using clinical and radiological measures. Trial start-up activities, including site selection, are underway, with patient enrollment and drug administration expected to begin as quickly as possible. Lucid-MS…

FridayAug 07, 2026 2:55 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory and commercial milestones amid growing interest in regenerative orthopedic solutions. GelrinC is an off-the-shelf, cell-free implant designed for a streamlined, single-step procedure that supports cartilage regeneration without the cell harvesting and laboratory processing required by some alternative approaches. Regentis is continuing enrollment in its U.S. clinical study, preparing for a potential FDA Premarket Approval submission, expanding commercialization efforts in Europe following CE Mark approval, and optimizing manufacturing for scalability and consistency. To view the full article, visit https://ibn.fm/mVCsB About Regentis Biomaterials Ltd. Regentis Biomaterials is a…

FridayAug 07, 2026 2:12 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Two-Pronged Approach to Neurological Health

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company focused on advancing innovative therapies and technologies, is developing a two-pronged strategy addressing neurological health through its investigational multiple sclerosis therapy Lucid-MS and its proprietary dietary supplement unbuzzd. Lucid-MS is designed to target PAD2, an enzyme associated with myelin degradation, with the goal of protecting and potentially restoring the myelin sheath rather than primarily modulating the immune system. The company submitted an IND application to the FDA for a Phase 2 trial and is supporting development through an imaging collaboration…

FridayAug 07, 2026 1:04 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Builds Strategic Position in Antibody Therapeutics Market

VERAXA Biotech (NASDAQ: VRXA) is developing next-generation antibody therapeutics across antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), two areas that continue to attract significant pharmaceutical investment. A recent article highlights major transactions to illustrate how differentiated antibody-engineering platforms can attract substantial financial commitments even before clinical development reaches advanced stages. VERAXA’s proprietary BiTAC platform supports a pipeline that includes bispecific ADCs, T-cell engagers and engineered antibody formats, potentially creating opportunities for future platform partnerships, licensing agreements or asset-level transactions. To view the full article, visit https://ibn.fm/sMjlp About VERAXA Biotech AG VERAXA is building a premier engine for the discovery and development of…

Site Search

Company Search

Category: QualityStocksNewsBreaks